We are live on
!
Find out more
ClearBridge Investments Portfolio holdings
AUM
$115B
1-Year Est. Return
24.78%
This Fund
S&P 500
This Quarter
Est. Return
+0.22%
1 Year Est. Return
+24.78%
3 Year Est. Return
+90.16%
5 Year Est. Return
+117.12%
10 Year Est. Return
+482.55%
AUM
$106B
AUM Growth
-$2.26B
(-2.1%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
19.49%
Holding
1,239
New
65
Increased
399
Reduced
411
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$378M |
| 2 |
Caterpillar
CAT
|
+$333M |
| 3 |
AGN
Allergan plc
AGN
|
+$294M |
| 4 |
PX
Praxair Inc
PX
|
+$226M |
| 5 |
Oracle
ORCL
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$286M |
| 2 |
MON
Monsanto Co
MON
|
+$271M |
| 3 |
COL
Rockwell Collins
COL
|
+$263M |
| 4 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$205M |
| 5 |
Kimberly-Clark
KMB
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.65% |
| 2 | Healthcare | 18.12% |
| 3 | Financials | 11.61% |
| 4 | Communication Services | 11.54% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AABA
651
DELISTED
Altaba Inc
AABA
| $790K | ﹤0.01% |
10,675
+2,375
| +29% | +$179K |
|
652
Rhythm Pharmaceuticals
RYTM
$7.72B
| $761K | ﹤0.01% |
38,264
+36,476
| +2,040% | +$968K |
|
|
DSL
653
DoubleLine Income Solutions Fund
DSL
$1.23B
| $743K | ﹤0.01% |
37,000
+1,500
| +4% | +$30.2K |
|
654
KKR & Co
KKR
$92.8B
| $743K | ﹤0.01% |
36,580
+5,196
| +17% | +$115K |
|
655
Federal Realty Investment Trust
FRT
$10.2B
| $728K | ﹤0.01% |
6,270
-200
| -3% | -$23.6K |
|
656
Cheniere Energy
LNG
$55.7B
| $724K | ﹤0.01% |
13,550
-2,730
| -17% | -$150K |
|
657
Magna International
MGA
$18.1B
| $724K | ﹤0.01% |
12,840
-50
| -0.4% | -$2.79K |
|
658
MDU Resources
MDU
$4.34B
| $718K | ﹤0.01% |
67,062
| – | – |
|
659
RELX
RELX
$62.4B
| $711K | ﹤0.01% |
34,056
| – | – |
|
|
DCT
660
DELISTED
DCT Industrial Trust Inc.
DCT
| $690K | ﹤0.01% |
12,250
-2,000
| -14% | -$113K |
|
661
Lloyds Banking Group
LYG
$90B
| $664K | ﹤0.01% |
178,369
+1,505
| +0.9% | +$5.83K |
|
662
Darden Restaurants
DRI
$24.1B
| $651K | ﹤0.01% |
7,640
| – | – |
|
663
CBRE Group
CBRE
$42.7B
| $640K | ﹤0.01% |
13,561
+2,489
| +22% | +$113K |
|
664
Western Midstream Partners
WES
$19.4B
| $639K | ﹤0.01% |
19,290
+9,040
| +88% | +$344K |
|
665
Northrop Grumman
NOC
$80.7B
| $637K | ﹤0.01% |
1,826
-30
| -2% | -$10K |
|
666
State Street SPDR S&P 500 ETF Trust
SPY
$818B
| $634K | ﹤0.01% |
2,410
-90,148
| -97% | -$24.6M |
|
667
KB Financial Group
KB
$42.6B
| $619K | ﹤0.01% |
10,677
| – | – |
|
668
EQT Corp
EQT
$32.3B
| $614K | ﹤0.01% |
23,732
| – | – |
|
669
CubeSmart
CUBE
$9.42B
| $612K | ﹤0.01% |
21,700
-2,290
| -10% | -$62.4K |
|
670
Eli Lilly
LLY
$1.06T
| $607K | ﹤0.01% |
7,848
| – | – |
|
671
Nutrien
NTR
$32B
| $566K | ﹤0.01% |
+11,974
| New | +$600K |
|
672
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $560K | ﹤0.01% |
6,385
| – | – |
|
673
Dick's Sporting Goods
DKS
$17.8B
| $553K | ﹤0.01% |
+15,790
| New | +$515K |
|
|
CBIO
674
Crescent Biopharma
CBIO
$610M
| $553K | ﹤0.01% |
+341
| New | +$709K |
|
675
Rogers Communications
RCI
$18.7B
| $551K | ﹤0.01% |
12,330
+3,261
| +36% | +$153K |
|
Similar funds
VAM
ClearBridge Investments's Q1 2018 Portfolio in Review
As of Q1 2018, ClearBridge Investments held 1,239 positions worth $106B, down 2.1% from $108B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
ClearBridge Investments's Q1 2018 filing shows 65 new, 399 increased, 411 reduced and 47 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 1,780,176 shares worth $94.1M. The largest sale was Amgen, an estimated $286M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- ClearBridge Investments's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 1,780,176 shares worth $94.1M.
- ClearBridge Investments added most to Equinix in Q1 2018, an estimated $378M increase.
- ClearBridge Investments's biggest Q1 2018 reduction was Amgen, cutting an estimated $286M.
- ClearBridge Investments fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $205M.
- ClearBridge Investments's ten largest holdings make up 19% of its $106B portfolio in Q1 2018.
- ClearBridge Investments opened 65 new positions and closed 47 in Q1 2018.
- ClearBridge Investments's portfolio value fell 2.1% quarter-over-quarter to $106B.
Based on ClearBridge Investments's 13F filing for Q1 2018, filed 15 May 2018.